Luo Hongyu H - OmicsDI

Show results for

Proteomics (2)
Metabolomics (1)

Organisms

Mus musculus (2)

Repository

iProX (2)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2026 (1)
2025 (1)
2024 (1)

Metabolite Name

((2R,3S,4S,5R,6S)-6-(2-(3-(Benzofuran-5-yl)propanoyl)-3-hydroxy-5-methylphenoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl methyl carbonate (1)
(+)-15,16-Dihydroxyoctadecanoic acid (1)
(+)-3,4-Didehydrocoronaridine (1)
(+)-7-epi-Syringaresinol 4'-glucoside (1)
(+)-Abscisic acid (1)
(+)-Bottrospicatol (1)
(+)-cis-3,4-Dihydrophenanthrene-3,4-diol (1)
(-)-Epigallocatechin 3-p-coumaroate (1)
(-)-Fumigaclavine B (1)
(-)-Jasmonic acid (1)
(-)-Menthol (1)
(-)-alpha-5,9-Dimethyl-2-(3-furylmethyl)-2'-hydroxy-6,7-benzomorphane (1)
(-)-jasmonoyl-L-isoleucine (1)
(-)-trans-3,4-Dihydro-4,8-dihydroxy-3-methyl-1H-2-benzopyran-1-one (1)
(10S)-Juvenile hormone III diol (1)
(10Z,14E,16E)-10,14,16-Octadecatrien-12-ynoic acid (1)
(14alpha,17beta,20S,22R)-14,20-Epoxy-17-hydroxy-1-oxowitha-3,5,24-trienolide (1)
(16-Benzyl-5,12-dihydroxy-5,7,14-trimethyl-13-methylidene-6,18-dioxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl) acetate (1)
(17E,19E,21E,23E,25E)-4,6,8,10,12,14,16,27-Octahydroxy-3-(1-hydroxyhexyl)-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one (1)
(17R)-17-Ethynyl-11-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol (1)
(1Ar,3S,4aS,7S,8aS)-3-[(1S,2R,3R)-3-[(2R,5S)-5,6-dimethylheptan-2-yl]-2-(2-hydroxyethyl)-2-methylcyclopentyl]-7-hydroxy-4a-methyl-2,3,5,6,7,8-hexahydro-1aH-naphtho[4,4a-b]oxiren-4-one (1)
(1E)-4-Oxobut-1-ene-1,2,4-tricarboxylate (1)
(1E,4S,5E,7R)-Germacra-1(10),5-dien-11-ol (1)
(1E,4Z,6a,8b,10a)-8-Angeloyloxy-10,15-dihydroxy-3-oxo-1,4,11(13)-germacratrien-12,6-olide (1)
(1R)-5-[2-[(1S,7As)-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol (1)
(1R,2R)-2-Amino-1-(4-nitrophenyl)propane-1,3-diol (1)
(1R,2S,3S,4R)-p-Menthane-2,3-diol (1)
(1R,2S,5S,6R,9S,10S)-3,6,17,20-Tetrahydroxy-6-(2-hydroxyacetyl)-1,5-dimethylpentacyclo[11.8.0.02,10.05,9.016,21]henicosa-13,16,18,20-tetraen-15-one (1)
(1R,3R,4R,5S,6S,8x)-1-Acetoxy-8-angeloyloxy-3,4-epoxy-5-hydroxy-7(14),10-bisaboladien-2-one (1)
(1R,6R)-1,4,5,5a,6,9-Hexahydrophenazine-1,6-dicarboxylate (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Multiple omics reveal link between the microbiota-gut-brain axis and intracranial aneurysm rupture

Intracranial aneurysms (IAs) are benign cerebrovascular maladies characterized by pathological dilatation in the walls of intracranial arteries. However, spontaneous subarachnoid hemorrhage (SAH) resulting from aneurysm rupture poses a grave threat to the patient's life. Accumulating evidence imp...

2024-12-13 | MTBLS10263 | MetaboLights

The ovarian tumor domain-containing protein 4 (OTUD4)-targeted ferroptosis inhibitor Maclekarpine E attenuates ulcerative colitis

This study aimed to evaluate the therapeutic effect of ME against UC and to elucidate its underlying molecular mechanism and potential target. ME was semi-synthesized on a gram scale via a biomimetic route. Its activity was assessed in an LPS-induced RAW264.7 macrophage model in vitro and a DSS-indu...

ORGANISM(S): Mus Musculus

2026-01-27 | PXD073619 |

Denervated muscle promotes nerve regeneration via retrograde metabolic signaling, revising the neural-dominated view of neuromuscular interactions

Peripheral nerve injury causes muscle atrophy due to slow axonal regeneration, highlighting an unmet therapeutic need. Although neuromuscular interactions are classically viewed as unidirectionally nerve-dominated, we show that acutely denervated muscle (adMu) regulates nerve regeneration via a retr...